Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. - Wikidata - wikimedia - TriplyDB

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

http://www.wikidata.org/entity/Q34677263

about

Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma.Benchmarking: contexts and details matter Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development DIFFERENTIAL PATHWAY DEPENDENCY DISCOVERY ASSOCIATED WITH DRUG RESPONSE ACROSS CANCER CELL LINES.Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies.Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.Molecular Mechanisms of Stem/Progenitor Cell Maintenance in the Adrenal Cortex.UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients.P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.Proteome analysis of adrenal cortical tumors.Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.CanProVar 2.0: An Updated Database of Human Cancer Proteome Variation.Genetics of Adrenocortical Development and Tumors.Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma.Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma-A New Look at an Old Drug.Progress in Endocrine Neoplasia.New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer.TumorFusions: an integrative resource for cancer-associated transcript fusions.A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.Challenges in surgical pathology of adrenocortical tumours.Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature.Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.ATR-101 inhibits cholesterol efflux and cortisol secretion by ATP-binding cassette transporters, causing cytotoxic cholesterol accumulation in adrenocortical carcinoma cells.A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma.Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.Overexpression of HSD17B4 exerts tumor suppressive function in adrenocortical carcinoma and is not associated with hormone excess.

P2860

Q26740687-7FF23AEC-9D2C-4DDC-9E3D-CC64D1F709E0 Q31165459-861C2C68-8E60-4915-9D6D-AA1B17957A57 Q33557718-08ADB80E-A087-493E-A266-E601FEED96EC Q33798092-DBB073B9-FFC5-4BDF-AA5A-F964BC8BD990 Q33876873-3A18A849-0D3B-422B-8F77-EC9213F39F49 Q33905628-91E0087E-571F-4212-B7E8-44BF4313BFF7 Q34550417-41778C78-9C75-4F44-AF9C-97F5D0C25D31 Q34680693-EDA31CE5-EB48-4629-B877-1B807B0FF2BD Q36112090-6CA7539F-2D90-44C8-B7E8-2AC76D814670 Q37263731-485A3668-6C56-4983-B648-FC5DB61E47ED Q37529740-DD966DCA-313B-48B8-8CE6-CD6E4D23959A Q37532946-A4432B00-1077-4E60-A106-3D418FECFA44 Q37705961-3FECF018-8665-40EA-841A-31BCDC02329F Q37716736-364C811E-FDE5-4EB6-97B2-DBE97A802493 Q38667837-C08DA9D3-3CA8-47B5-A79C-BD67D42D90BD Q38801063-2EF8B853-D13E-4D6F-BEF2-894F70D62BCC Q38814667-1B76AAD9-2695-461C-8EB5-13110234822A Q38860968-80F8939D-00E3-4EBD-AA73-955CF27C6A6E Q38888303-F42CE6E0-958B-4C27-803C-9EA8FF9535F2 Q39035325-8F029F2E-9C88-484B-A1A2-0662D07188F7 Q39098937-CB265845-2893-4C27-8544-1350449FFE9A Q39286333-6090160E-1BE6-41BD-8959-753B0B57309C Q40053275-ACE5C82B-74FC-45CC-A995-A31D6CB832DC Q40179966-2BDAA8A3-915B-42FC-B9EA-748E963EC881 Q42285779-2670DFCC-9C21-47C8-8B12-D22A1245D179 Q42371552-3E65E792-82E5-460F-9D0F-FAAAF09FD7E7 Q47207132-9E5AFA86-8495-4437-BF31-2C037E6E5D9C Q47239499-7CDB5486-B052-40E1-9182-2358E7E03A28 Q47557794-F1924334-D11E-46E1-AB05-A5876C8442AA Q47576824-86C1CD81-B55E-445F-8BBA-D541425AA968 Q47616676-6CBCAB77-704E-41AD-8756-B898FF2F47B2 Q47857157-AEF87423-CE4D-4D7F-963F-A822733C600E Q47934716-6C9A5F94-B6BD-46A4-B7DE-33001F88AB1E Q48015308-7E67F37C-CDF1-4FA8-BE03-AB85352949C0 Q48100155-5E15FE59-A690-4D13-AF49-78B08C55478A Q48108818-5CF0675A-945E-4EDD-B421-D528183BEF5A Q48121227-9D3DC6E7-56D3-41A8-95E6-1331E1848EDB Q48260919-74D41DD2-DEE4-4995-8C0A-8D1634927332 Q48305502-4D3ABB46-C1F1-434F-B004-9E2CDBC048B7 Q49207970-67CE8425-C41C-4C39-B137-CCC2200D4E38

P2860

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

http://www.wikidata.org/entity/Q34677263

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@ast

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@en

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@nl

type

label

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@ast

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@en

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@nl

prefLabel

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@ast

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@en

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@nl

P1433

Q34677263-A8DCF0FF-A501-4247-9A49-DB5C31A8B6F8

P1476

Q34677263-3AE2CD22-D2EF-443D-848F-F965FD90FCC5

P2093

Q34677263-00BDB328-75B8-4D79-89EA-B667A45F5FF1

Q34677263-19159FA7-46BD-4BA6-83D4-DA6B4060A764

Q34677263-1C5651DB-5D13-4823-9804-1C35F4575DD3

Q34677263-2B15A93A-FAB3-4A5A-BE2B-0F7F6450A674

Q34677263-30E76606-0484-4804-A3E6-C52980DEBC73

Q34677263-38F0285C-1043-4EF3-9886-3149F42CD1FA

Q34677263-3F4E81C7-F7C8-4F1A-B65B-FCDAE5364883

Q34677263-5064D35D-3AC3-415F-8443-C5A86EC72145

Q34677263-5265D51D-1046-48EE-A97B-2FD8ADE98710

Q34677263-531E4E68-2E3C-4A74-AA37-43B70BF76D4D

P2860

Q34677263-136D3B54-F8A5-493A-8A63-3A9527E575B9

Q34677263-15B194A7-6B09-48ED-9361-5895DACE97F0

Q34677263-18B38368-8694-4B16-BE1B-35426C9963AA

Q34677263-1DFF1CD4-4572-4A59-93C4-FE4FC5A66B36

Q34677263-1EEF05C0-55BD-4D6A-86AC-BA16C9D49CE2

Q34677263-2A04F6AA-6298-4DCE-B681-1EB71710E239

Q34677263-2D350718-0A21-403D-A728-0D28B5413952

Q34677263-2F47278C-713B-4976-A8F2-5C6909C22A8A

Q34677263-2FD3433F-764E-4911-9976-594BF7EE6FB5

Q34677263-30DBA989-399E-4F1B-9987-897CA3F6586A

P304

Q34677263-DA757134-E320-4424-94A5-56615BEAEE81

P31

Q34677263-0929EB71-887E-484C-94E3-E3D1436451C7

P356

Q34677263-299B0551-4EA7-421C-B0FD-7E5ABF95B22C

P433

Q34677263-5E860B15-83DD-4770-A0B7-544D429DECCA

P478

Q34677263-43772D71-F671-4C3E-AF20-0A4334C5CCAE

P50

Q34677263-539F2A0F-6DB7-45CB-B905-8259AA465004

Q34677263-5A45C8F6-5B8E-40F3-8A58-49D0069492B0

Q34677263-5C39B5F2-3641-4493-8442-C60AB39EF9B9

Q34677263-7CCA1ADA-A865-4BE9-BCD9-451A606204A1

Q34677263-8B9DE359-9F50-475C-841F-AF2826A68EFC

Q34677263-917CBADC-A93D-46EF-BA23-57A5E32523D2

Q34677263-A10914B2-CB2E-46CF-AA2F-8221CDA69E71

Q34677263-AE486865-D727-45EB-8100-DAB9470AAA48

Q34677263-E8D63E46-23AF-4769-8814-69683B91B909

Q34677263-F2B794F8-0F1A-49FB-9D09-D661176AE7CF

P577

Q34677263-F53759F8-3EDD-4330-9196-0B6E08D4DD4A

P698

Q34677263-A9853C13-DEA4-48F2-9EAB-0805B5FE1AD0

P932

Q34677263-3B41199B-F9F7-4D4C-9E33-0E010F39F540

P356

J.CCELL.2016.04.002

P1433

P1476

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

@en

P2093

A Gordon Robertson

http://www.w3.org/2001/XMLSchema#string

Andrew D Cherniack

http://www.w3.org/2001/XMLSchema#string

Anthony J Gill

http://www.w3.org/2001/XMLSchema#string

Antonio M Lerario

http://www.w3.org/2001/XMLSchema#string

Benjamin J Raphael

http://www.w3.org/2001/XMLSchema#string

Bradley A Murray

http://www.w3.org/2001/XMLSchema#string

David A Wheeler

http://www.w3.org/2001/XMLSchema#string

Electron Kebebew

http://www.w3.org/2001/XMLSchema#string

Gary D Hammer

http://www.w3.org/2001/XMLSchema#string

Guillaume Assie

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational heterogeneity in cancer and the search for new cancer-associated genes

A census of human cancer genes

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Discovery and saturation analysis of cancer genes across 21 tumour types

Signatures of mutational processes in human cancer

Highly recurrent TERT promoter mutations in human melanoma

Telomeres and human disease: ageing, cancer and beyond

MLL translocations, histone modifications and leukaemia stem-cell development

Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells.

Inferring tumour purity and stromal and immune cell admixture from expression data

P304

723-736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCELL.2016.04.002

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Ciriello

Kimberly J Bussey

Felix Beuschlein

Jérôme Bertherat

Matthew Meyerson

Mouhammed Amir Habra

Cancer Genome Atlas Research Network

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27165744

http://www.w3.org/2001/XMLSchema#string

P932

4864952

http://www.w3.org/2001/XMLSchema#string